| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.085 | 0.1 |